Updated Sep 15, 2011
Centro Studi GISED was established in 2002 as a nonprofit organisation to develop independent clinical research in Dermatology and to promote an Evidence Based approach to the clinical management of skin disorders . Initially, activities were mainly focused on the coordination of the research projects of the Italian Group for Epidemiologic Research in Dermatology (GISED). Subsequently, they expanded to embrace any kind of clinical research, medical humanities, and health education.
In 2003, Centro Studi GISED got formal recognition for its activity and mandate by Regione Lombardia being entered in the Enterprise Registry (Registro delle Imprese) of the Bergamo Chamber of Commerce with number 2096.
In October 2003, Centro Studi GISED signed an agreement with the Regional Hospital, Ospedali Riuniti di Bergamo, and established its headquarter at the Department of Dermatology of the same Hospital.
Since 2003, following an agreement with the University of Milan, Centro Studi GISED is participating in the Inter-universitary Centre Thomas Chalmers for the development of systematic reviews and their implementation in clinical practice.
In March 2009, Centro Studi GISED moved its headquarters at Mazzoleni pavilion of the hospital detachment Matteo Rota, in the officies made available by FROM (Research Foundation of Ospedale Maggiore Bergamo), a non-profit foundation headed by Prof. Tiziano Barbui.
From 2009 to 2011, Centro Studi GISED had signed a partnership with the Science and Technology Park Kilometro Rosso establishing an office as "Centro Studi GISED Imaging" at the facilities of the Park in association with the Integrated Centre for Medicine and Medical Jobs (MEL), primarily dedicated to the development of innovative imaging systems in dermatology and image analysis.
In 2011, the Clinical Points of Centro Studi GISED were estabilished with the aim to provide an adequate clinical response to skin problems, according to the concept that technological development in medicine must be translated into better treatments for patients at an affordable cost.